Biotechnology Small-Cap Cancer Drug Developer Agenus’ Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom – Agenus (NASDAQ:AGEN) Read more
Biotechnology Bristol Myers Squibb’s Acquired Adagrasib Combo Therapy May Benefit Colorectal Cancer Patients With Certain Mutation – Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology Small Cap-Cardiff Oncology Outlines Data From Discontinued Colorectal Cancer Trial, Stock Soars – Cardiff Oncology (NASDAQ:CRDF) Read more